Does Empagliflozin And Linagliptin Interact with Diuretics?
CDI records a moderate classification for Empagliflozin And Linagliptin and Diuretics. The stored summary is: Coadministration with empagliflozin increases urine volume and frequency, enhancing potential for volume depletion. Monitor volume status and renal function. The mechanism involves increased urine volume and frequency of voids. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Empagliflozin And Linagliptin Class
- Dipeptidyl Peptidase 4 Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Increased urine volume and frequency of voids
What To Tell Your Doctor or Pharmacist
If you are taking Empagliflozin And Linagliptin and your doctor is considering prescribing Diuretics (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider